The Longest Telomeres: a General Signature of Adult Stem Cell Compartments
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Human Chromosome‐Specific Aneuploidy Is Influenced by DNA
Article Human chromosome-specific aneuploidy is influenced by DNA-dependent centromeric features Marie Dumont1,†, Riccardo Gamba1,†, Pierre Gestraud1,2,3, Sjoerd Klaasen4, Joseph T Worrall5, Sippe G De Vries6, Vincent Boudreau7, Catalina Salinas-Luypaert1, Paul S Maddox7, Susanne MA Lens6, Geert JPL Kops4 , Sarah E McClelland5, Karen H Miga8 & Daniele Fachinetti1,* Abstract Introduction Intrinsic genomic features of individual chromosomes can contri- Defects during cell division can lead to loss or gain of chromosomes bute to chromosome-specific aneuploidy. Centromeres are key in the daughter cells, a phenomenon called aneuploidy. This alters elements for the maintenance of chromosome segregation fidelity gene copy number and cell homeostasis, leading to genomic instabil- via a specialized chromatin marked by CENP-A wrapped by repeti- ity and pathological conditions including genetic diseases and various tive DNA. These long stretches of repetitive DNA vary in length types of cancers (Gordon et al, 2012; Santaguida & Amon, 2015). among human chromosomes. Using CENP-A genetic inactivation in While it is known that selection is a key process in maintaining aneu- human cells, we directly interrogate if differences in the centro- ploidy in cancer, a preceding mis-segregation event is required. It was mere length reflect the heterogeneity of centromeric DNA-depen- shown that chromosome-specific aneuploidy occurs under conditions dent features and whether this, in turn, affects the genesis of that compromise genome stability, such as treatments with micro- chromosome-specific aneuploidy. Using three distinct approaches, tubule poisons (Caria et al, 1996; Worrall et al, 2018), heterochro- we show that mis-segregation rates vary among different chromo- matin hypomethylation (Fauth & Scherthan, 1998), or following somes under conditions that compromise centromere function. -
Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant
Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children’s Research Hospital Departments of Hematology, Patient Education, and Biomedical Communications. Funds were provided by St. Jude Children’s Research Hospital, ALSAC, and a grant from the Plough Foundation. This document is not intended to take the place of the care and attention of your personal physician. Our goal is to promote active participation in your care and treatment by providing information and education. Questions about individual health concerns or specifi c treatment options should be discussed with your physician. For more general information on sickle cell disease, please visit our Web site at www.stjude.org/sicklecell. Copyright © 2009 St. Jude Children’s Research Hospital How did bone marrow (stem cell) transplants begin for children with sickle cell disease? Bone marrow (stem cell) transplants have been used for the treatment and cure of a variety of cancers, immune system diseases, and blood diseases for many years. Doctors in the United States and other countries have developed studies to treat children who have severe sickle cell disease with bone marrow (stem cell) transplants. How does a bone marrow (stem cell) transplant work? 2 In a person with sickle cell disease, the bone marrow produces red blood cells that contain hemoglobin S. This leads to the complications of sickle cell disease. • To prepare for a bone marrow (stem cell) transplant, strong medicines, called chemotherapy, are used to weaken or destroy the patient’s own bone marrow, stem cells, and infection fi ghting system. -
The Diversity of Plant Sex Chromosomes Highlighted Through Advances in Genome Sequencing
G C A T T A C G G C A T genes Review The Diversity of Plant Sex Chromosomes Highlighted through Advances in Genome Sequencing Sarah Carey 1,2 , Qingyi Yu 3,* and Alex Harkess 1,2,* 1 Department of Crop, Soil, and Environmental Sciences, Auburn University, Auburn, AL 36849, USA; [email protected] 2 HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA 3 Texas A&M AgriLife Research, Texas A&M University System, Dallas, TX 75252, USA * Correspondence: [email protected] (Q.Y.); [email protected] (A.H.) Abstract: For centuries, scientists have been intrigued by the origin of dioecy in plants, characterizing sex-specific development, uncovering cytological differences between the sexes, and developing theoretical models. Through the invention and continued improvements in genomic technologies, we have truly begun to unlock the genetic basis of dioecy in many species. Here we broadly review the advances in research on dioecy and sex chromosomes. We start by first discussing the early works that built the foundation for current studies and the advances in genome sequencing that have facilitated more-recent findings. We next discuss the analyses of sex chromosomes and sex-determination genes uncovered by genome sequencing. We synthesize these results to find some patterns are emerging, such as the role of duplications, the involvement of hormones in sex-determination, and support for the two-locus model for the origin of dioecy. Though across systems, there are also many novel insights into how sex chromosomes evolve, including different sex-determining genes and routes to suppressed recombination. We propose the future of research in plant sex chromosomes should involve interdisciplinary approaches, combining cutting-edge technologies with the classics Citation: Carey, S.; Yu, Q.; to unravel the patterns that can be found across the hundreds of independent origins. -
Cytogenetics of Fraxinus Mandshurica and F. Quadrangulata: Ploidy Determination and Rdna Analysis
Tree Genetics & Genomes (2020) 16:26 https://doi.org/10.1007/s11295-020-1418-6 ORIGINAL ARTICLE Cytogenetics of Fraxinus mandshurica and F. quadrangulata: ploidy determination and rDNA analysis Nurul Islam-Faridi1,2 & Mary E. Mason3 & Jennifer L. Koch4 & C. Dana Nelson5,6 Received: 22 July 2019 /Revised: 1 January 2020 /Accepted: 16 January 2020 # The Author(s) 2020 Abstract Ashes (Fraxinus spp.) are important hardwood tree species in rural, suburban, and urban forests of the eastern USA. Unfortunately, emerald ash borer (EAB, Agrilus planipennis) an invasive insect pest that was accidentally imported from Asia in the late 1980s–early 1990s is destroying them at an alarming rate. All North American ashes are highly susceptible to EAB, although blue ash (F. quadrangulata) may have some inherent attributes that provide it some protection. In contrast Manchurian ash (F. mandshurica) is relatively resistant to EAB having coevolved with the insect pest in its native range in Asia. Given its level of resistance, Manchurian ash has been considered for use in interspecies breeding programs designed to transfer resistance to susceptible North American ash species. One prerequisite for successful interspecies breeding is consistency in chromosome ploidy level and number between the candidate species. In the current study, we cytologically determined that both Manchurian ash and blue ash are diploids (2n) and have the same number of chromosomes (2n =2x = 46). We also characterized these species’ ribosomal gene families (45S and 5S rDNA) using fluorescence in situ hybridization (FISH). Both Manchurian and blue ash showed two 45S rDNA and one 5S rDNA sites, but blue ash appears to have an additional site of 45S rDNA. -
Genetic Manipulation of Stem Cells Eleni Papanikolaou1,2*, Kalliopi I
logy & Ob o st ec e tr n i y c s G Papanikolaou et al. Gynecol Obstetric 2011, S:6 Gynecology & Obstetrics DOI: 10.4172/2161-0932.S6-001 ISSN: 2161-0932 Review Article Open Access Genetic Manipulation of Stem Cells Eleni Papanikolaou1,2*, Kalliopi I. Pappa1,3 and Nicholas P. Anagnou1,2 1Laboratory of Cell and Gene Therapy, Centre for Basic Research, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece 2Laboratory of Biology, University of Athens School of Medicine, Athens, Greece 3First Department of Obstetrics and Gynecology, University of Athens School of Medicine, Alexandra Hospital, Athens, Greece Abstract Stem cells have the remarkable potential for self-renewal and differentiation into many cell types in the body during early life and development. In addition, in many tissues they constitute a source of internal repair system, dividing essentially without limit to replenish damaged or dead cells. After division, each new cell has the potential either to retain the stem cell status or to differentiate to a more specialized cell type, such as a red blood cell, a brain cell or a heart cell. Until recently, three types of stem cells from animals and humans have been characterized, i.e. embryonic stem cells, fetal stem cells and somatic adult stem cells. However, in late 2007, researchers accomplished another breakthrough by identifying conditions that allow some specialized adult cells to be “reprogrammed” genetically to assume a stem cell-like state. These cells, called induced pluripotent stem cells (iPSCs), express genes and factors important for maintaining the unique properties and features of embryonic stem cells. -
Genetics and Stem Cell Research A.Genetics
7: Genetics and Stem Cell Research A.Genetics 1. Introduction The principal special feature of genetics research is that the result of the study applies not only to the proband but also influences her lineage both in the past and in the future. For example genetic studies demonstrated Thomas Jefferson’s sexual relationship with his slave Sally Hemings and defined their descendants to this day. As we all know from television, genetic studies can be done from any tissue fragment that contains DNA so that studies of surgical specimens, biopsy materials, hair, epithelium and blood samples can all be utilized for extensive genetic studies. 2. Sampling Some DNA is more medically valuable than other. Samples from isolated populations in which a particular disorder is prevalent have a much greater probability of yielding the causal gene(s) because they have fewer genome variations than in the general population. Once isolated, the genetic material associated with the disorder has a good chance of yielding novel diagnostic and/or therapeutic approaches for the disorder. 3. Property rights A persistent question is whether the providers of the genetic material have any rights to the products created from their genetic material. These days, most consent forms are written explicitly to exclude intellectual property rights from the subjects. As might be imagined, this smacks of exploitation in the developing world. Negotiation of a monetary return to the community has sometimes been concluded. Important and lucrative products have been derived from individuals’ genomes without their receiving royalties or other compensation. However, the knowledge, technical expertise, and capital needed to make a useful product from a blood or tissue sample come from the company not the donor. -
The Amazing Stem Cell What Are They? Where Do They Come From? How Are They Changing Medicine? Stem Cells Are “Master Cells”
The Amazing Stem Cell What are they? Where do they come from? How are they changing medicine? Stem cells are “master cells” Stem cells can be “guided” to become many other cell types. Stem Cell Bone cell Self-renewed stem cell Brain cell Heart muscle Blood cell cell There are several types of stem cells, each from a unique source Embryonic stem cells* • Removed from embryos created for in vitro fertilization after donation consent is given. (Not sourced from aborted fetuses.) • Embryos are 3-5 days old (blastocyst) and have about 150 cells. • Can become any type of cell in the body, also called pluripotent cells. • Can regenerate or repair diseased tissue and organs. • Current use limited to eye-related disorders. * Not used by Mayo Clinic. Adult stem cells • Found in most adult organs and tissues, including bone marrow. • Often taken from bone marrow in the hip. • Blood stem cells can be collected through apheresis (separated from blood). • Can regenerate and repair diseased or damaged tissues (regenerative medicine). • Can be used as specialized “drugs” to potentially treat degenerative conditions. • Currently tested in people with neurological and heart disease. Umbilical cord blood stem cells • Found in blood in placenta and umbilical cord after childbirth. • Have the ability to change into specialized cells (like blood cells), also called progenitor cells. • Parents choose to donate umbilical cord blood for use in research, or have it stored for private or public banks. • Can be used in place of bone marrow stem cell transplants in some clinical applications. Bioengineered stem cells • Regular adult cells (e.g., blood, skin) reprogrammed to act like embryonic stem cells (induced pluripotent stem cells). -
Arabidopsis MZT1 Homologs GIP1 and GIP2 Are Essential for Centromere Architecture
Arabidopsis MZT1 homologs GIP1 and GIP2 are essential for centromere architecture Morgane Batzenschlagera, Inna Lermontovab, Veit Schubertb, Jörg Fuchsb, Alexandre Berra, Maria A. Koinic, Guy Houlnéa, Etienne Herzoga, Twan Ruttenb, Abdelmalek Aliouaa, Paul Franszc, Anne-Catherine Schmita, and Marie-Edith Chaboutéa,1 aInstitut de biologie moléculaire des plantes, CNRS, Université de Strasbourg, 67000 Strasbourg, France; bLeibniz Institute of Plant Genetics and Crop Plant Research OT Gatersleben, D-06466 Stadt Seeland, Germany; and cSwammerdam Institute for Life Sciences, University of Amsterdam, 1098 XH, Amsterdam, The Netherlands Edited by James A. Birchler, University of Missouri, Columbia, MO, and approved May 12, 2015 (received for review April 2, 2015) Centromeres play a pivotal role in maintaining genome integrity Previously, we characterized the γ-tubulin complex protein 3- by facilitating the recruitment of kinetochore and sister-chromatid interacting proteins (GIPs), GIP1 and GIP2 (Table S1), as es- cohesion proteins, both required for correct chromosome segre- sential for the recruitment of γ-tubulin complexes at microtubule gation. Centromeres are epigenetically specified by the presence (MT) organizing centers in Arabidopsis (7, 8). This function seems of the histone H3 variant (CENH3). In this study, we investigate the conservedinthehumanandSchizosaccharomyces pombe GIP role of the highly conserved γ-tubulin complex protein 3-interact- homologs named mitotic spindle organizing protein 1 (MZT1) ing proteins (GIPs) in Arabidopsis centromere regulation. We show (9–11). More recently, we localized GIPs at the nucleoplasm pe- that GIPs form a complex with CENH3 in cycling cells. GIP depletion riphery, close to chromocenters, where they modulate the nuclear in the gip1gip2 knockdown mutant leads to a decreased CENH3 architecture (12, 13). -
Nano-Biosensor for Monitoring the Neural Differentiation of Stem Cells
nanomaterials Review Nano-Biosensor for Monitoring the Neural Differentiation of Stem Cells Jin-Ho Lee 1,2,†, Taek Lee 1,2,† and Jeong-Woo Choi 1,2,* 1 Department of Chemical and Biomolecular Engineering, Sogang University, 35 Baekbeom-ro (Sinsu-dong), Mapo-gu, Seoul 121-742, Korea; [email protected] (J.-H.L.); [email protected] (T.L.) 2 Institute of Integrated Biotechnology, Sogang University, 35 Baekbeom-ro (Sinsu-dong), Mapo-gu, Seoul 121-742, Korea * Correspondence: [email protected]; Tel.: +82-2-718-1976; Fax: +82-2-3273-0331 † These authors contributed equally to this work. Academic Editors: Chen-Zhong Li and Ling-Jie Meng Received: 6 July 2016; Accepted: 17 November 2016; Published: 28 November 2016 Abstract: In tissue engineering and regenerative medicine, monitoring the status of stem cell differentiation is crucial to verify therapeutic efficacy and optimize treatment procedures. However, traditional methods, such as cell staining and sorting, are labor-intensive and may damage the cells. Therefore, the development of noninvasive methods to monitor the differentiation status in situ is highly desirable and can be of great benefit to stem cell-based therapies. Toward this end, nanotechnology has been applied to develop highly-sensitive biosensors to noninvasively monitor the neural differentiation of stem cells. Herein, this article reviews the development of noninvasive nano-biosensor systems to monitor the neural differentiation of stem cells, mainly focusing on optical (plasmonic) and eletrochemical methods. The findings in this review suggest that novel nano-biosensors capable of monitoring stem cell differentiation are a promising type of technology that can accelerate the development of stem cell therapies, including regenerative medicine. -
Stem Cell Research: an Overview
Biochemistry & Molecular Biology Letters Review | Vol 3 Iss 2 Stem Cell Research: An Overview Shatadru Bhattacharjee* Department of Pharmacognosy, Dr. BC Roy College of Pharmacy, West Bengal, India *Corresponding author: Shatadru B, Dr. BC Roy College of Pharmacy, West Bengal, India, Email- [email protected] Received: March 03, 2017; Accepted: March 19, 2017; Published: March 24, 2017 Abstract A primary cell can reproduce itself or give rise to more specialized cell type is known as stem cell. The stem cell is the primogenitor at the top of the family tree among all type of cell [1-7]. One blood stem cell gives birth to red blood cells (RBC), white cells (WBC) and platelets stem cells that vary in their developmental capacity. A multi-potent stem cell can give birth to several types of mature cell. A pluripotent stem cell can give birth to all types of adult tissue cells and extra embryonic tissue cells which support embryonic development inside fetus[8-14]. A totipotent stem cell can give birth to a new individual given appropriate maternal support. The current growth of stem cell research is quiet good from last few decades. Stem cell therapy has capabilities of regenerating any human tissue damaged by injury, disease or ageing could be available within a few years. In this review there are few discussion related to current stem cell research and development [15-21]. Keywords: Stem cell; Regenerative medicine; Cell biology Introduction Stem cells have the remarkable potential in the development of several different type of cell in the body during early life and growth [22-28]. -
Basic Pluripotent Stem Cell Culture Protocols Maria Borowski∗, Maria Giovino-Doherty, Lan Ji, Meng-Jiao Shi, Kelly P
Basic pluripotent stem cell culture protocols Maria Borowski∗, Maria Giovino-Doherty, Lan Ji, Meng-Jiao Shi, Kelly P. Smith and Joseph Laning, Massachusetts Stem Cell Bank, University of Massachusetts Medical School, Shrewsbury, MA 01545 USA Abstract Stem cell research is a rapidly expanding field with the potential to develop therapeutic agents to treat diseases as well as study disease development from early stages. The culture of human pluripotent stem cells shares many of the same protocols as standard mammalian cell culture. However, the successful culture and maintenance of human pluripotent stem cells (hPSCs) in an undifferentiated state requires additional consider- ations to ensure that cells maintain their key characteristics of self-renewal and pluripotency. There are several basic techniques needed for the culturing of mammalian cells, including thawing frozen stocks, plating cells in culture vessels, changing media, passaging and cryopreservation. The protocols in this document represent a subset of the standard operating procedures used to maintain and culture stem cells at the Massachusetts Human Stem Cell Bank, and have been thoroughly testing and verified. A Stem cell culture considerations Stem cell research is a rapidly expanding field with the potential to develop therapeutic agents to treat diseases as well as study disease development from early stages. However, to fulfill this promise, researchers need to have access to standardized protocols for the development, maintenance and differentiation of these unique cells. Such “best practices” will allow comparisons of different studies and hasten the refinement of these techniques. Such standardization can be driven by resources such as StemBook and by stem cell banks. -
Stem Cell Therapy and Gene Transfer for Regeneration
Gene Therapy (2000) 7, 451–457 2000 Macmillan Publishers Ltd All rights reserved 0969-7128/00 $15.00 www.nature.com/gt MILLENNIUM REVIEW Stem cell therapy and gene transfer for regeneration T Asahara, C Kalka and JM Isner Cardiovascular Research and Medicine, St Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA, USA The committed stem and progenitor cells have been recently In this review, we discuss the promising gene therapy appli- isolated from various adult tissues, including hematopoietic cation of adult stem and progenitor cells in terms of mod- stem cell, neural stem cell, mesenchymal stem cell and ifying stem cell potency, altering organ property, accelerating endothelial progenitor cell. These adult stem cells have sev- regeneration and forming expressional organization. Gene eral advantages as compared with embryonic stem cells as Therapy (2000) 7, 451–457. their practical therapeutic application for tissue regeneration. Keywords: stem cell; gene therapy; regeneration; progenitor cell; differentiation Introduction poietic stem cells to blood cells. The determined stem cells differentiate into ‘committed progenitor cells’, which The availability of embryonic stem (ES) cell lines in mam- retain a limited capacity to replicate and phenotypic fate. malian species has greatly advanced the field of biologi- In the past decade, researchers have defined such com- cal research by enhancing our ability to manipulate the mitted stem or progenitor cells from various tissues, genome and by providing model systems to examine including bone marrow, peripheral blood, brain, liver cellular differentiation. ES cells, which are derived from and reproductive organs, in both adult animals and the inner mass of blastocysts or primordial germ cells, humans (Figure 1).